Nat. Rev. Neurol. doi: /nrneurol

Slides:

Advertisements

Similar presentations

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.

Advertisements

Nat. Rev. Neurol. doi: /nrneurol

Figure 2. Proposed phenotypes of type 2 DCs

Figure 1 miRNA expression in multiple sclerosis lesions

by Xiao Z. Shen, You Li, Liang Li, Kandarp H. Shah, Kenneth E

Macrophage-Derived Matrix VesiclesNovelty and Significance

Figure 3 Life expectancy at birth in all countries included

Figure 2 Systemic abnormalities in AD

Figure 1 Histopathology of low-grade glioma

Figure 4 Time course of the development of physiological changes

Figure 4 Host damage from infection-related inflammatory

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Radiation-induced effects on tumour cells

Jeffrey F. Scott, Lopa M. Das, Sayeeda Ahsanuddin, Yuqi Qiu, Amy M

Figure 2 Systemic immune responses to cryptococcal antigen

Nat. Rev. Neurol. doi: /nrneurol

Figure 4 Simplified T cell and antigen presenting

Figure 2 Main functions of IL-1

Figure 3 The T-cell cytokine tree in IBD

Figure 3 Proportion of patients for whom NEDA

Figure 5 Number of AHSCT procedures for

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 2 Molecular pathways involved in the regulation of T-cell differentiation and cytokine production Figure 2 | Molecular pathways involved in the.

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Associations between baseline cerebrospinal fluid

Figure 3 Hypothetical mechanisms of smoking-associated

Figure 2 Poststroke plasticity and recovery

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 Altered innate immune functions after sepsis

Fig. 2. Engraftment of CART-EGFRvIII and cytokine modulation in the peripheral blood. Engraftment of CART-EGFRvIII and cytokine modulation in the peripheral.

Figure 3 Differentiation and functional control of T-cell subsets

Figure 4 Macrophages in liver inflammation

Figure 4 Lifestyle and environmental factors affect

Metabolic Reprogramming of Immune Cells in Cancer Progression

Figure 1 The trajectory of cognitive ageing

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Endocrinol. doi: /nrendo

Volume 81, Issue 5, Pages (March 2014)

Figure 1 Proportional motor recovery in the upper limb

Figure 3 Stroke-related deaths and DALYs by country development status

Figure 4 11C-PK11195-PET scans showing the evolution of neuroinflammation in a patient after stroke Figure 4 | 11C-PK11195-PET scans showing the evolution.

Figure 3 Current model of immunopathogenesis in CIDP

Figure 6 Combining population-wide and high-risk strategies

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 Potential interplay between physiological

Nat. Rev. Neurol. doi: /nrneurol

Figure 5 Cytokine release and stimulation of cells during alemtuzumab treatment Cytokine release and stimulation of cells during alemtuzumab treatment.

Figure 2 APCs from laquinimod-treated mice inhibit differentiation of Tfh cells APCs from laquinimod-treated mice inhibit differentiation of Tfh cells.

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 Timing of the effects of deep brain stimulation

Figure 3 Tumours secrete factors that cause systemic immunosuppression

Figure 1 A large number of genes are potentially associated with CIPN

The molecular mechanisms of hemodialysis vascular access failure

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Neurol. doi: /nrneurol

Volume 15, Issue 3, Pages (April 2016)

Mohamed A. Saleh et al. BTS 2016;1:

Figure 7 VEGF as a mediator of neuroinflammatory disease

Figure 4 Bile-acid-induced TGR5 signalling pathways in macrophages

Figure 3 Craniospinal irradiation proton therapy for medulloblastoma

Figure 5 ADP-induced inflammatory responses require P2Y12 receptors in human microgliaIncreasing concentrations of ADP (5, 50, and 200 μM) increased tumor.

Figure 3 Underlying mechanisms of TREG cells in atherosclerosis

Effect of CIA and treatment with 3,4-dichloropropionaniline (DCPA) on production of key serum inflammatory factors. Effect of CIA and treatment with 3,4-dichloropropionaniline.

Figure 2. Odds ratios (ORs) from the multivariate logistic regression analysis and hazard ratios (HRs) from the Cox regression analysis Odds ratios (ORs)

Increased proinflammatory cytokine production is dependent on both the training interval and the resting time. Increased proinflammatory cytokine production.

Figure 3 DMF promotes an anti-inflammatory cytokine B-cell profile

Alternatively activated macrophages as therapeutic agents for kidney disease: in vivo stability is a key factor Senthilkumar Alagesan, Matthew D. Griffin

Wolbachia-induced responses of specific cell types.

Figure 3 The possible role of keratinocytes in CRPS pathophysiology

Presentation transcript:

Nat. Rev. Neurol. doi:10.1038/nrneurol.2017.69 Figure 1 Dynamic changes in microglial marker levels and profiles over time after intracerebral haemorrhage. Figure 1 | Dynamic changes in microglial marker levels and profiles over time after intracerebral haemorrhage. Top panel, dashed red curve: microglial M1-like response exhibits a decreasing trend in the first 14 days. Top panel, dashed blue curve: microglial M2-like response exhibits an increasing trend in the first 14 days. Bottom panel: microglia exhibit an M1-like response as early as 6 h after intracerebral haemorrhage (ICH), as shown by upregulation of proinflammatory cytokines such as IL-1β, IL-6, tumour necrosis factor (TNF) and inducible nitric oxide synthase (iNOS). M2 markers, such as arginase-1 (Arg1), chitinase-like protein 3 (also known as Ym1), CD206, CD163 and IL-10, start to increase on day 1 after ICH. Transforming growth factor-β (TGFβ) is upregulated from day 7 until day 14 post-ICH. Although a mixed M1-like and M2-like microglial phenotype is evident during days 1 to 3, the balance of evidence supports an M1 to M2 phenotype switch in the first 7 days. IFNγ levels increase on day 7 after ICH, and levels of most proinflammatory cytokines return to baseline on day 14. Lan, X. et al. (2017) Modulators of microglial activation and polarization after intracerebral haemorrhage Nat. Rev. Neurol. doi:10.1038/nrneurol.2017.69